BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.750
-0.150 (-5.17%)
Feb 24, 2026, 4:00 PM EST - Market closed
BioLineRx Employees
BioLineRx had 28 employees as of December 31, 2024. The number of employees decreased by 51 or -64.56% compared to the previous year.
Employees
28
Change (1Y)
-51
Growth (1Y)
-64.56%
Revenue / Employee
$454,821
Profits / Employee
-$106,321
Market Cap
11.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 28 | -51 | -64.56% |
| Dec 31, 2023 | 79 | 30 | 61.22% |
| Dec 31, 2022 | 49 | 11 | 28.95% |
| Dec 31, 2021 | 38 | 0 | - |
| Dec 31, 2020 | 38 | -4 | -9.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioAtla | 61 |
| CytoMed Therapeutics | 43 |
| Lunai Bioworks | 29 |
| Longeveron | 25 |
| BioCardia | 20 |
| NewcelX | 15 |
| Cocrystal Pharma | 11 |
| Traws Pharma | 7 |
BLRX News
- 3 months ago - BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - BioLineRx (BLRX) Surpasses Q3 EPS Estimates Despite Revenue Shortfall - GuruFocus
- 3 months ago - BioLineRx (BLRX) Q3 Revenue Declines Amid New Joint Venture - GuruFocus
- 3 months ago - BioLineRx GAAP EPS of $0.00 beats by $0.54, revenue of $0.43M misses by $0.24M - Seeking Alpha
- 3 months ago - BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - Earnings Scheduled For November 24, 2025 - Benzinga
- 3 months ago - BioLine Rx's Earnings: A Preview - Benzinga
- 3 months ago - BioLineRx Q3 2025 Earnings Preview - Seeking Alpha